REGENERON PHARMACEUTICALS, INC. Available-for-sale Securities, Gross Realized Gain (Loss)
REGENERON PHARMACEUTICALS, INC. (REGN) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $500.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2014-08-05.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2014-08-05
- REGENERON PHARMACEUTICALS, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2013-06-30 was $500.00K.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month |
|---|---|---|
| 2013-06-30 | $500.00K 10-Q · filed 2014-08-05 | $500.00K 10-Q · filed 2014-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |